HK1136006A1 - 呼腸孤病毒突變種以及其製備和使用方法 - Google Patents
呼腸孤病毒突變種以及其製備和使用方法Info
- Publication number
- HK1136006A1 HK1136006A1 HK10101956.8A HK10101956A HK1136006A1 HK 1136006 A1 HK1136006 A1 HK 1136006A1 HK 10101956 A HK10101956 A HK 10101956A HK 1136006 A1 HK1136006 A1 HK 1136006A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- making
- methods
- mutant reoviruses
- reoviruses
- mutant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/13—Tumour cells, irrespective of tissue of origin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US93925507P | 2007-05-21 | 2007-05-21 | |
PCT/CA2008/000964 WO2008141448A1 (en) | 2007-05-21 | 2008-05-21 | Mutant reoviruses and methods of making and using |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1136006A1 true HK1136006A1 (zh) | 2010-06-18 |
Family
ID=40031362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10101956.8A HK1136006A1 (zh) | 2007-05-21 | 2010-02-24 | 呼腸孤病毒突變種以及其製備和使用方法 |
Country Status (15)
Country | Link |
---|---|
US (1) | US20080292594A1 (zh) |
EP (1) | EP2150613B1 (zh) |
JP (1) | JP2010527593A (zh) |
CN (2) | CN101679953A (zh) |
AR (1) | AR066649A1 (zh) |
AU (1) | AU2008253505B2 (zh) |
CA (1) | CA2680661C (zh) |
DK (1) | DK2150613T3 (zh) |
ES (1) | ES2611455T3 (zh) |
HK (1) | HK1136006A1 (zh) |
IL (1) | IL200690A (zh) |
MX (1) | MX2009012420A (zh) |
TW (1) | TW200909581A (zh) |
WO (1) | WO2008141448A1 (zh) |
ZA (1) | ZA200907017B (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0720624D0 (en) * | 2007-10-20 | 2007-11-28 | Academisch Ziekenhuis Leiden | Viral Modification |
WO2009052617A1 (en) * | 2007-10-22 | 2009-04-30 | Oncolytics Biotech Inc. | Treatment regime for proliferative disorders |
MX2010012857A (es) * | 2008-05-27 | 2010-12-20 | Oncolytics Biotech Inc | Supresion de produccion de citoquina proinflamatoria durante la terapia de reovirus oncolitico. |
JP2011520993A (ja) * | 2008-05-27 | 2011-07-21 | オンコリティクス バイオテク,インコーポレーテッド | 間質圧力の調節並びに腫瘍崩壊性ウイルスの送達及び分布 |
SG190418A1 (en) | 2010-12-02 | 2013-07-31 | Oncolytics Biotech Inc | Liquid viral formulations |
ES2630012T3 (es) | 2010-12-02 | 2017-08-17 | Oncolytics Biotech Inc. | Formulaciones virales liofilizadas |
US20160271193A1 (en) | 2013-11-15 | 2016-09-22 | Oncolytics Biotech Inc. | Oncolytic viruses and increased cancer treatment regimens |
CA3018307A1 (en) | 2016-02-16 | 2017-08-24 | Osaka University | Pharmaceutical composition for use in treating fibrosis |
KR20210098202A (ko) * | 2020-01-31 | 2021-08-10 | 바이로큐어 주식회사 | 레오바이러스를 유효성분으로 포함하는 대장염의 예방 또는 치료용 조성물 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US5023252A (en) * | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US6565831B1 (en) * | 1999-02-24 | 2003-05-20 | Oncolytics Biotech Inc. | Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
US6110461A (en) * | 1997-08-13 | 2000-08-29 | Oncolytics Biotech Inc. | Reovirus for the treatment of neoplasia |
US6136307A (en) * | 1997-08-13 | 2000-10-24 | Oncolytics Biotech Inc. | Reovirus for the treatment of cellular proliferative disorders |
CA2334857C (en) * | 1998-06-12 | 2012-03-20 | Mount Sinai School Of Medicine Of The City University Of New York | Interferon inducing genetically engineered attenuated viruses |
TWI289158B (en) * | 2000-08-10 | 2007-11-01 | Oncolytics Biotech Inc | Method of producing infectious reovirus |
NZ524937A (en) * | 2000-11-09 | 2004-10-29 | Oncolytics Biotech Inc | Methods for determining susceptibility of a cell to reovirus infection and for diagnosing proliferative disease treatable with reovirus |
IL157304A0 (en) * | 2001-03-16 | 2004-02-19 | Oncolytics Biotech Inc | Method of extracting virus from cell culture |
US7163678B2 (en) * | 2002-11-07 | 2007-01-16 | Oncolytics Biotech Inc. | Reovirus for the treatment of ral-mediated cellular proliferative disorders |
WO2005111200A1 (en) * | 2004-05-17 | 2005-11-24 | Universite De Montreal | Novel strains of reoviruses and methods of uses thereof |
CA2617600A1 (en) * | 2005-08-01 | 2007-09-07 | University Technologies International, Inc. | Attenuated reovirus |
-
2008
- 2008-05-20 TW TW097118468A patent/TW200909581A/zh unknown
- 2008-05-20 AR ARP080102139A patent/AR066649A1/es unknown
- 2008-05-21 JP JP2010508676A patent/JP2010527593A/ja active Pending
- 2008-05-21 MX MX2009012420A patent/MX2009012420A/es active IP Right Grant
- 2008-05-21 EP EP08748334.3A patent/EP2150613B1/en active Active
- 2008-05-21 AU AU2008253505A patent/AU2008253505B2/en active Active
- 2008-05-21 CA CA2680661A patent/CA2680661C/en active Active
- 2008-05-21 ES ES08748334.3T patent/ES2611455T3/es active Active
- 2008-05-21 WO PCT/CA2008/000964 patent/WO2008141448A1/en active Application Filing
- 2008-05-21 DK DK08748334.3T patent/DK2150613T3/en active
- 2008-05-21 CN CN200880016669A patent/CN101679953A/zh active Pending
- 2008-05-21 CN CN201410339446.7A patent/CN104195115A/zh active Pending
- 2008-05-21 US US12/124,522 patent/US20080292594A1/en not_active Abandoned
-
2009
- 2009-09-02 IL IL200690A patent/IL200690A/en active IP Right Grant
- 2009-10-08 ZA ZA2009/07017A patent/ZA200907017B/en unknown
-
2010
- 2010-02-24 HK HK10101956.8A patent/HK1136006A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2680661A1 (en) | 2008-11-27 |
DK2150613T3 (en) | 2017-01-30 |
EP2150613B1 (en) | 2016-10-19 |
CN101679953A (zh) | 2010-03-24 |
MX2009012420A (es) | 2009-12-09 |
AR066649A1 (es) | 2009-09-02 |
IL200690A (en) | 2014-02-27 |
ZA200907017B (en) | 2010-12-29 |
US20080292594A1 (en) | 2008-11-27 |
WO2008141448A1 (en) | 2008-11-27 |
AU2008253505B2 (en) | 2014-09-04 |
AU2008253505A1 (en) | 2008-11-27 |
TW200909581A (en) | 2009-03-01 |
IL200690A0 (en) | 2011-08-01 |
ES2611455T3 (es) | 2017-05-09 |
JP2010527593A (ja) | 2010-08-19 |
CA2680661C (en) | 2018-05-29 |
CN104195115A (zh) | 2014-12-10 |
EP2150613A1 (en) | 2010-02-10 |
EP2150613A4 (en) | 2011-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1254895A1 (zh) | 苄基苯衍生物及使用方法 | |
EG27167A (en) | Microemulsifiers and methods of making and using same | |
HK1147254A1 (en) | 5-anilinoimidazopyridines and methods of use 5- | |
EP2279291A4 (en) | COFERONE AND METHOD FOR THE PRODUCTION AND USE THEREOF | |
EP2262450A4 (en) | IMPLANTS AND METHODS OF USE | |
HK1136006A1 (zh) | 呼腸孤病毒突變種以及其製備和使用方法 | |
IL222947A0 (en) | Luminaire and methods of use | |
IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
EP2508600A4 (en) | MUTANT ENZYME AND ITS APPLICATION | |
ZA200905626B (en) | Adjuvants and methods of using them | |
ZA200710173B (en) | Tygecycline and methods of preparing 9-nitrominocycline | |
GB0719577D0 (en) | Microimplant devices and methods of making and use thereof | |
IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
HK1149933A1 (zh) | 二氮咔唑和其使用方法 | |
IL206125A0 (en) | Azaindolizines and methods of use | |
IL209548A0 (en) | Diazacarbazoles and methods of use | |
TWI370107B (en) | Novel methods for making and using halosilylgermanes | |
EP2052054A4 (en) | ANTIOXIDANTS AND METHODS OF MAKING ANTIOXIDANTS | |
GB201002469D0 (en) | Parthenote-derived stem cells and methods of making and using them | |
EP2170988A4 (en) | POLYSTYRENE COMPOSITIONS AND METHODS FOR PREPARING AND USING SAME | |
ZA201004894B (en) | Nuctraceutical composition and methods of use | |
ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
IL186277A0 (en) | Dnt-maleate and methods of preparation thereof | |
IL192552A0 (en) | Dnt-succinate and methods of preparation thereof | |
ZA201004893B (en) | Nuctraceutical composition and methods of use |